Ferronyl™ iron supplement

Ferronyl™ iron supplement
Product Description

Ferronyl™ iron supplement isan ideal source of essentially pure iron with low toxicity,minimal metallic taste andexcellent bioavailability. Ferronyl™ iron supplement is elemental iron (Fe) with high (> 98%) iron content,manufactured by the chemical decomposition of iron pentacarbonyl. The resulting iron particles are small, uniform spheres of high purity, with only traces of carbon, oxygen and nitrogen. High iron content results in lower use levels to achieve the same daily intake levels compared with ferrous(Fe2+) salts.

Ashland Industries Europe GmbH

  • CH
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

Ashland Industries Europe GmbH

  • CH
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator

More Products from Ashland Industries Europe GmbH (22)

  • Aqualon™ ethylcellulose

    Product Aqualon™ ethylcellulose

    Aqualon™ ethylcellulose (EC) is a cellulose ether distinguished by its versatility. Aqualon™ EC is soluble in a wide range of organic solvents and is typically used as a non-swellable, insoluble component in matrix or coating systems. Aqualon™ EC can be used to coat one or more active ingredients of a...
  • Klucel™ hydroxypropylcellulose

    Product Klucel™ hydroxypropylcellulose

    Klucel™ hydroxypropylcellulose (HPC) is a nonionic water-soluble cellulose ether with a remarkable combination of properties. It combines organic solvent solubility, thermoplasticity and surface activity with the aqueous thickening and stabilizing properties characteristic of other water-soluble cellulose ...
  • Aqualon™ CMC BET sodium carboxymethylcellulose

    Product Aqualon™ CMC BET sodium carboxymethylcellulose

    aqualon™ CMC BET sodium carboxymethylcellulose are viscosity modifiers for diluents and excellent suspending agents, easily dispersible in water, and compatible with most active ingredients.  To learn more visit https://www.ashland.com/industries/pharmaceutical/parenteral-dosage/aqualon-cmc-ph-bet
  • Blanose™ sodium carboxymethylcellulose

    Product Blanose™ sodium carboxymethylcellulose

    Blanose™ CMC are anionic, water-soluble cellulose ethers, produced by reacting alkalicellulose with monochloroacetic acid under controlled conditions. Blanose™ CMC is available in a variety of grades with different degrees of substitution,viscosity and particle size to meet specific formulation requirement...
  • Cavamax* native cyclodextrins

    Product Cavamax* native cyclodextrins

    The molecular structure of cyclodextrins creates a bucket-like cavity that can complex with molecules or functional groups on molecules to improve solubility of poorly soluble compounds. The same mechanism makes these excipients capable of masking unpleasant taste/odor and stabilizing drugs that are prone ...
  • Cavitron™ cyclodextrins (hydroxypropyl betacyclodextrin)

    Product Cavitron™ cyclodextrins (hydroxypropyl betacyclodextrin)

    cavitron™ cyclodextrins (hydroxypropyl betacyclodextrin) are the perfect substances for increasing solubility and enhancing bioavailability. They are manufactured to high purity standards for low bioburden and endotoxin.
    To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-...
  • Natrosol™ hydroxyethylcellulose

    Product Natrosol™ hydroxyethylcellulose

    Natrosol™ 250 hydroxyethylcellulose (HEC) is a nonionic, water-soluble cellulose ether. Natrosol™ 250 HEC is easily dispersed in cold or hot water to give solutions of varying viscosities and desired properties, though it is insoluble in organic solvents. It is used in solutions and gels to control rheolog...
  • Pharmasolve™ N-methyl-2-pyrrolidone

    Product Pharmasolve™ N-methyl-2-pyrrolidone

    Pharmasolve™ N-methyl-2-pyrrolidone (NMP) is a versatile solubilizer for one-component systems. It is a water-miscible polar aprotic solvent with high interfacial activity. Pharmasolve™ NMP is manufactured in a facility with ISO 9001:2015 and EXCiPACT GMP certifications. It is used as a drug solubilizer an...
  • Plasdone™ povidone

    Product Plasdone™ povidone

    Plasdone™ povidones are a family of water-soluble polymers based on N-vinylpyrrolidone that combine a unique set of properties for application in a wide variety of dosage forms. Plasdone™ povidones are commonly used as binders for the development of tablet formulations, whether manufactured by wet granulat...
  • Plasdone™ S-630 copovidone

    Product Plasdone™ S-630 copovidone

    Plasdone™ S-630 copovidone is a 60:40 random, linear copolymer produced by the free radical polymerization of N-vinyl-2-pyrollidone and vinyl acetate. The pyrrolidone ring is responsible for excellent water solubility, adhesion, film forming and solubilization properties, while the vinyl acetate monom...
  • Polyplasdone™ crospovidone

    Product Polyplasdone™ crospovidone

    Polyplasdone™ crospovidone superdisintegrants are synthetic, insoluble, but rapidly swellable, crosslinked homopolymers of N-vinyl-2-pyrrolidone. Crospovidone provides rapid disintegration and dissolution to oral solid dosage forms. Polyplasdone crospovidone particles are granular and porous compared ...
  • PVP-iodine Complex

    Product PVP-iodine Complex

    PVP Iodine complex kills microorganisms on contact, is safer and easier to use than classic iodine preparations and has low systemic toxicity. In addition, it forms films that protect open wounds. Because it is soluble in water as well as in organic solvents, it an be formulated in powders, tablets, lozeng...

Ashland Industries Europe GmbH resources (7)

  • News Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program

    WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel™ bioresorbable mPEG-PDLLA pharmaceutical excipient in the review cycle of the FDA Novel Excipient Review Pilot Program.
  • Video Rapid Response to the European Food Safety Authority (EFSA) Ban on TiO2 as a Food Additive as it Relates to Film Coatings

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. The session discusses: Challenges faced when removing TiO2 from film coatings Aquarius TM TF. A reliable and effective alternative to TiO2 in film coatings Improved process economics with Aquarius Genesis TF high-solids TiO2-free film coating
  • News Ashland announces Klucel™ xtend HPC matrix former for extended-release tablets

    Wilmington, Del., Oct. 3, 2022 - Ashland is introducing Klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency. 
    Until now, there were limited options for managing the release profile of formulations, especially high dose, controlled release formulations. Ashland’s step change klucel™ xtend HPC has been shown to match the release profile of hypromellose controlled-release formulations at half the polymer concentration. The highly reduced polymer concentration achievable with klucel™ xtend HPC offers the possibility of smaller pills or higher dosage, if necessary. This new excipient offers unrivaled versatility across a broad range of APIs in every manufacturing process: dry granulation, wet-granulation, direct compression, and holt-melt extrusion.
  • Video Excipient Engineering and Design to Improve Processing of Oral Controlled Release Formulations

    Hydrophilic polymer matrix systems are widely used in oral controlled drug delivery because of their flexibility to obtain a desirable drug release profile, cost effectiveness, and broad regulatory acceptance.

    Hydroxypropyl methyl cellulose (HPMC) is the key matrix former used in the majority of formulations. As controlled release formulations continue to evolve, so does the need for more robust and flexible matrix forming polymers. Join this learning lab session to:
    understand key mechanistic aspects of hypromellose-enabled hydrophilic matrix tablets discover how polymer engineering results in optimized Benecel HPMC grades (new Benecel XR & XRF HPMC grades) learn about the advantages of Benecel DC Hypromellose in flow and loss-in-weight (LIW) feeding for continuous manufacturing compared to regular HPMC grades



    Click here to register

  • News Ashland announces Polyplasdone™ Plus multifunctional disintegrant for improved pharmaceutical process throughput

    Wilmington, Del., June 20, 2023 - Ashland is introducing Polyplasdone™ Plus, a co-processed multifunctional direct compression superdisintegrant containing a glidant and lubricant. Saving time and simplifying development, the multifunctional disintegrant offers superior powder flow and lubrication during pharmaceutical manufacturing. This innovative product eliminates two manufacturing steps and simplifies equipment setup while simultaneously delivering improved tablet hardness and helping ensure the production of consistent, high-quality products in batch and continuous manufacturing.
  • Brochure Ashland Pharma Overview

    Ashland offers a range of excipients and technologies, polymer expertise, and technical support for oral solids, liquids, and parenteral dosage forms. Our solutions include controlled release, binders, disintegrants, solubles, stabilizers, rheology modifiers, and resorbable polymers.
  • News Ashland launches 2021 Environment, Social, and Governance Report

    Ashland has raised the bar on its business-driven environment, social and governance (ESG) targets by demonstrating a clear link between its long-range strategic plans and detailed ESG progress.